| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/15/2010 | EP2228447A2 Cloning and characterizing of genes associated with long-term memory |
| 09/15/2010 | EP2228446A1 Secreted and transmembrane polypeptieds and nucleic acids encoding the same |
| 09/15/2010 | EP2228390A1 Therapeutic uses of monoclonal antibodies to the angiotensin-II type-1 receptor |
| 09/15/2010 | EP2228389A2 Antibodies against vascular endothelial growth factor 2 |
| 09/15/2010 | EP2228388A1 Protected Arg-Glu-Arg polypeptides and uses thereof |
| 09/15/2010 | EP2228387A2 Polypeptides derived from amyloid precursor peptide (app) and their uses |
| 09/15/2010 | EP2228385A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 09/15/2010 | EP2228384A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 09/15/2010 | EP2228381A2 Alpha-MSH antagonist dipeptide conjugates |
| 09/15/2010 | EP2228071A1 Intra-vascular kidney gene therapy with plasmid encoding BMP-7 |
| 09/15/2010 | EP2228070A2 Modulation of granulosa cell apoptosis |
| 09/15/2010 | EP2228069A1 Antagonists of protein kinase c-epsilon (pkcepsilon) and their use for the treatment of aberrant glucose metabolism associated therewith. |
| 09/15/2010 | EP2228068A1 Therapeutic agent for cerebral ischemic injury |
| 09/15/2010 | EP2227488A1 Fviii peptides and their use in tolerising haemophiliacs |
| 09/15/2010 | EP2227483A1 Soluble forms of hendra and nipah virus f glycoprotein and uses thereof |
| 09/15/2010 | EP2227246A1 Treatment of fibroses and liver disorders |
| 09/15/2010 | EP2227245A2 Combination of protein tyrosine phosphatase inhibitors and human growth hormone for the treatment of muscle atrophy and related disorders |
| 09/15/2010 | EP2227244A1 Cgrp as a therapeutic agent |
| 09/15/2010 | EP2227243A2 A pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate |
| 09/15/2010 | EP2227242A2 Bone morphogenic protein binding peptide |
| 09/15/2010 | EP2227236A2 Methods and compositions for reducing activity of the atrial natriuretic peptide receptor and for treatment of diseases |
| 09/15/2010 | EP2227218A2 Composition for treatment and prevention of hair loss and premature graying of hair |
| 09/15/2010 | EP1931697B1 Il-17a and il-17f antagonists and methods of using the same |
| 09/15/2010 | EP1909816B1 Cnf1 bacterial toxin protein from e. coli as analgesic |
| 09/15/2010 | EP1673387B1 Il-21 derivatives |
| 09/15/2010 | EP1576179B1 Methods and compositions for inducing apoptosis in cancer cells |
| 09/15/2010 | EP1536839B1 Combination therapy comprising omega-interferon for treating infection with hepatitis c virus or yellow fever virus |
| 09/15/2010 | EP1536837B1 Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors |
| 09/15/2010 | EP1532241B1 Rationally designed polysaccharide lyases derived from chondroitinase b |
| 09/15/2010 | EP1430140B1 N-terminally truncated isoforms of pde3a cyclic phosphodiesterases |
| 09/15/2010 | EP1351681B1 Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts |
| 09/15/2010 | EP1303596B1 Morpholino antisense oligomers as enzyme inhibitors for improving pharmacokinetics of a drug |
| 09/15/2010 | EP1250055B1 Immune modulation with death receptor-induced apoptosis |
| 09/15/2010 | CN1752211B Recombination target fused protein for treating acquired immunodeficiency syndrome |
| 09/15/2010 | CN101835894A EBI3, DLX5, NPTXl and CDKN3 for target genes of lung cancer therapy and diagnosis |
| 09/15/2010 | CN101835892A CDCA1 peptide and pharmaceutical agent comprising the same |
| 09/15/2010 | CN101835801A Transferrin variants and conjugates |
| 09/15/2010 | CN101835800A SDF-1-based glycosaminoglycan antagonists and methods of using same |
| 09/15/2010 | CN101835799A Modulators of hypersensitivity reactions |
| 09/15/2010 | CN101835793A Mutant double cyclized receptor peptides inhibiting beta1-adrenoceptor antibodies |
| 09/15/2010 | CN101835792A FOXM1 peptide and medicinal agent comprising the same |
| 09/15/2010 | CN101835493A Complexes between an amphiphilic polymer and an osteogenic protein of the bmps family |
| 09/15/2010 | CN101835486A Pharmaceutical composition and related methods |
| 09/15/2010 | CN101835485A Activin-ACTRIIA antagonists and uses for treating or preventing breast cancer |
| 09/15/2010 | CN101835484A Antibody-mediated disruption of quorum sensing in bacteria |
| 09/15/2010 | CN101835483A Treatment of atherosclerosis |
| 09/15/2010 | CN101835482A Polymeric linkers containing pyridyl disulfide moieties |
| 09/15/2010 | CN101835463A Herbicide-safener combination |
| 09/15/2010 | CN101831435A Preparation and application of IL-15 isoform protein of mice |
| 09/15/2010 | CN101831433A Zebra fish P-selectin gene, encoded protein and application thereof |
| 09/15/2010 | CN101831005A PH sensitive type chitosan derivant and application thereof in pharmaceutics |
| 09/15/2010 | CN101830974A Amyloid-beta(1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use therof |
| 09/15/2010 | CN101830971A Novel antiangiogenic polypeptide |
| 09/15/2010 | CN101830969A Balsam pear hypoglycemic MC-JJ0104 polypeptide analogue by microwave-accelerated solid-phase synthesis and application thereof |
| 09/15/2010 | CN101829325A Pharmaceutical composition for treatment of diseases caused by IL-6 production |
| 09/15/2010 | CN101829324A Treatment of intermediate-and high-grade non-hodgkins lymphoma with anti-CD20 antibody |
| 09/15/2010 | CN101829322A Application of superantigen fusion protein cell factor in preparation of anti-solid tumor medicament |
| 09/15/2010 | CN101829320A Collagen gel and preparation method thereof |
| 09/15/2010 | CN101829319A Pharmaceutical compositions and methods for insulin treatment |
| 09/15/2010 | CN101829318A Use of IL-28 and IL-29 to treat cancer and autoimmune disorders |
| 09/15/2010 | CN101829317A Application of delta opiate receptor antagonist ICI174, 864 for preparing haemorrhagic shock resisting medicine |
| 09/15/2010 | CN101829316A Lactalbumin hydrolysate and application thereof in preparing glucose-lowering medicament |
| 09/15/2010 | CN101829125A Compound combined formulation for preventing and treating osteoarthrosis and preparation method thereof |
| 09/15/2010 | CN101829050A Natural brain protein hydrolysate injection and preparation method thereof |
| 09/15/2010 | CN101829048A Eye drop and preparation method thereof |
| 09/15/2010 | CN101828713A Composition against infection with rotavirus and process for producing the same |
| 09/15/2010 | CN101828661A Health-care food for improving moisture of skin and removing wrinkle |
| 09/15/2010 | CN101333258B Fusion polypeptide with antimicrobial and wound healing promoting function |
| 09/15/2010 | CN101245110B Recombined leukocyte inhibition factor and hirudo nipponica former peg-and-socket joint protein and pharmaceutical composition |
| 09/15/2010 | CN101244261B Biological agent containing non-renaturation recombinant protein, preparation method and application thereof |
| 09/15/2010 | CN101210239B Double-functional molecule for dissolving thrombus and inhibiting blood platelet aggregate and use thereof |
| 09/15/2010 | CN101181636B Compound vaccine composition for preventing and controlling human viral infection, compound vaccine vaginal mist and uses thereof |
| 09/15/2010 | CN101139578B Double-functional staphylokinase mutant having platelet aggregation resistance and fibrinolytic activity, application and preparation method thereof |
| 09/15/2010 | CN101125205B Polyethylene decorative nevin fibrinolytic enzyme and its preparation method |
| 09/15/2010 | CN101069742B Pancreatic kininogenase tablet and preparing method |
| 09/14/2010 | US7795495 utility of beta -synuclein and peptides derived therefrom as anti-amyloidogenic agents ; neurodegenerative diseases such as Alzheimer's and Parkinson's diseases; screening for new anti-amyloidogenic agents |
| 09/14/2010 | US7795422 Chemically synthesized siRNA molecule; nucleic acids with a pyrimidine modification; inflammatory, respiratory, pulmonary, autoimmune, cardiovascular, neurodegenerative, and/or proliferative and cancerous diseases, traits, or conditions |
| 09/14/2010 | US7795416 Telomerase repressor proteins and nucleic acid compositions encoding the same are provided. The subject repressor proteins bind to a repressor site in the TERT minimal promoter, e.g., a Site C site, and thereby inhibit TERT expression. |
| 09/14/2010 | US7795407 Metastatic breast and colon cancer regulated genes |
| 09/14/2010 | US7795406 Agent for treating leishmania infections |
| 09/14/2010 | US7795400 producing a mature Factor IX-containing polypeptide from a proprotein of Factor IX (proFIX) by contacting the proFIX or the conjugate thereof with an effective amount of functional PC5 |
| 09/14/2010 | US7795399 Stable therapeutic proteins |
| 09/14/2010 | US7795396 COOH-terminally added cysteine variant of the beta interferon |
| 09/14/2010 | US7795391 Protein showing enhanced expression in cancer cells |
| 09/14/2010 | US7795389 Antagonizing TGF-beta activity with various ectodomains TGF-beta receptors used in combination or as fusion proteins |
| 09/14/2010 | US7795388 circularly permuted chaperonin peptide molecule, comprising a new carboxyl-terminal amino acid and a new amino-terminal amino acid and a reordered chaperonin polypeptide sequence; can assemble into double-ringed chaperonin structures which can organize into higher order structures such as nanofilaments |
| 09/14/2010 | US7795387 detecting the decreased transcription of messenger RNA transcribed from an RDCVF1 or RDCVF2 polypeptide, in the eye of a human, wherein said decreased transcription is diagnostic of such human's suffering from retinal dystrohy |
| 09/14/2010 | US7795386 selectively inhibit alpha v beta 3 integrin; used in the treatment of diseases associated with angiogenesis and cancer |
| 09/14/2010 | US7795385 treating septic shock using RC-3095 (H-D-Tpi-Gln-Trp-Ala-Val-Gly-His-Leu-psi-Leu-NH2 ) |
| 09/14/2010 | US7795384 expressed with high efficiency and stability in host cells; suitable for high effectively producing short peptides without lysine residues; digesting the fusion protein with trypsinase and carboxypeptidase B, thereby forming peptides C1 and C2 |
| 09/14/2010 | US7795381 Helper T lymphocytes epitope for use in induction of antitumor responses in melanoma; antiproliferative agents |
| 09/14/2010 | US7795378 Erectile dysfunction |
| 09/14/2010 | US7795305 CDDO-compounds and combination therapies thereof |
| 09/14/2010 | US7795235 Semi-soft c-class immunostimulatory oligonucleotides |
| 09/14/2010 | US7795232 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers |
| 09/14/2010 | US7795226 Control of radiation injury |
| 09/14/2010 | US7795225 inhibitors of chondrosarcoma cell growth that are useful as anti-cancer and anti-tumor agents; inhibitors are peptides having sequences related to cleavage regions of the proenzyme forms of matrix metalloproteinases and that can inhibit the activity of matrix metalloproteinases |
| 09/14/2010 | US7795224 Tumor associated antigen peptides and use of same as anti-tumor vaccines |
| 09/14/2010 | US7795223 Treatment of inflammatory airway disease |
| 09/14/2010 | US7795222 administering peptide comprising claimed amino acid sequence; insulin-like growth factor; therapy for vision defects, skin disorders; wound healing agents; antiulcer agents |